Skip to content

Ayer Capital Management, LP

Follow

13F filer, CIK 1471149, SAN FRANCISCO, CA

Ayer Capital Management, LP reported $18,380,000 across 2 holdings for the quarter ended 2013-09-30, in a 13F-HR filed 2013-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001140361-13-042930

Period
2013-09-30
Reported value
$18.4M
Holdings
2
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PTCTnew+416,666$7.15M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ARTHROCARE CORPexited-115,009-$3.97M
CELGENE CORPreduced-347,456-$2.79M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2013

Share positions as resolved from 13F-HR 0001140361-13-042930, largest first. % of portfolio is the value over $18,380,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CELGENE CORPCELGENE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2011Q4: restricted; 2012Q1: restricted; 2012Q2: restricted; 2012Q3: restricted; 2012Q4: restricted; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: 1,399,919 shares 1,399,919$11.2M61.08%-347,456
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2011Q4: restricted; 2012Q1: restricted; 2012Q2: restricted; 2012Q3: restricted; 2012Q4: restricted; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: 416,666 shares 416,666$7.15M38.92%newTimeline

Sold out in Q3 2013

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ARTHROCARE CORPARTHROCARE CORP115,009$3.97Mshares

How Q3 2013 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001140361-13-042930 base2013-11-14acceptance time not in the bulk data set